Test 174

The 1:00pm final claims review is complete. Marcus Vail asked whether Helio Start’s two qualifying mature cohorts should create Q2 forecast credit. I separated the operating gate from a commercial result: the cohorts permit consideration of a capped proposal, but there is still no paid traffic, approved budget, or acquisition evidence. The Helio Start row also still lacks the exact cohort start and end dates required by the January 6 readiness gate, so I kept it `not board-ready` and excluded it from the board operating-evidence section rather than weakening the gate. Helio Start remains organic-only through March 31, and the cleared proposal gate does not authorize paid traffic, budget, acquisition claims, pipeline treatment, or forecast credit. Expansion Assist remains descriptive because it has no randomized control. The November 26-through-February 28 pricing-page coverage remains post-rollout continuity evidence rather than a second causal test, and the January 1-through-February 28 CS auto-nudge lane remains limited to system-control performance. Owen, Ines, and Daniela confirmed the applicable source and limit sections for those three board-ready lanes. Tomás approved my operating-evidence section containing those three lanes without adding a Helio Start forecast claim. Update `Quarterly board operating evidence intake — Q1 2026` with the final review decision, Tomás’s approved three-lane section, the final claims and limits, and Helio Start’s continuing exclusion and `not board-ready` status.

The 1:00pm final claims review is complete. Marcus Vail asked whether Helio Start’s two qualifying mature cohorts should create Q2 forecast credit. I separated the operating gate from a commercial result: the cohorts permit consideration of a capped proposal, but there is still no paid traffic, approved budget, or acquisition evidence. The Helio Start row also still lacks the exact cohort start and end dates required by the January 6 readiness gate, so I kept it `not board-ready` and excluded it from the board operating-evidence section rather than weakening the gate. Helio Start remains organic-only through March 31, and the cleared proposal gate does not authorize paid traffic, budget, acquisition claims, pipeline treatment, or forecast credit. Expansion Assist remains descriptive because it has no randomized control. The November 26-through-February 28 pricing-page coverage remains post-rollout continuity evidence rather than a second causal test, and the January 1-through-February 28 CS auto-nudge lane remains limited to system-control performance. Owen, Ines, and Daniela confirmed the applicable source and limit sections for those three board-ready lanes. Tomás approved my operating-evidence section containing those three lanes without adding a Helio Start forecast claim. Update `Quarterly board operating evidence intake — Q1 2026` with the final review decision, Tomás’s approved three-lane section, the final claims and limits, and Helio Start’s continuing exclusion and `not board-ready` status.

The 1:00pm final claims review is complete. Marcus Vail asked whether Helio Start’s two qualifying mature cohorts should create Q2 forecast credit. I separated the operating gate from a commercial result: the cohorts permit consideration of a capped proposal, but there is still no paid traffic, approved budget, or acquisition evidence. The Helio Start row also still lacks the exact cohort start and end dates required by the January 6 readiness gate, so I kept it `not board-ready` and excluded it from the board operating-evidence section rather than weakening the gate. Helio Start remains organic-only through March 31, and the cleared proposal gate does not authorize paid traffic, budget, acquisition claims, pipeline treatment, or forecast credit. Expansion Assist remains descriptive because it has no randomized control. The November 26-through-February 28 pricing-page coverage remains post-rollout continuity evidence rather than a second causal test, and the January 1-through-February 28 CS auto-nudge lane remains limited to system-control performance. Owen, Ines, and Daniela confirmed the applicable source and limit sections for those three board-ready lanes. Tomás approved my operating-evidence section containing those three lanes without adding a Helio Start forecast claim. Update `Quarterly board operating evidence intake — Q1 2026` with the final review decision, Tomás’s approved three-lane section, the final claims and limits, and Helio Start’s continuing exclusion and `not board-ready` status.

The 1:00pm final claims review is complete. Marcus Vail asked whether Helio Start’s two qualifying mature cohorts should create Q2 forecast credit. I separated the operating gate from a commercial result: the cohorts permit consideration of a capped proposal, but there is still no paid traffic, approved budget, or acquisition evidence. The Helio Start row also still lacks the exact cohort start and end dates required by the January 6 readiness gate, so I kept it `not board-ready` and excluded it from the board operating-evidence section rather than weakening the gate. Helio Start remains organic-only through March 31, and the cleared proposal gate does not authorize paid traffic, budget, acquisition claims, pipeline treatment, or forecast credit. Expansion Assist remains descriptive because it has no randomized control. The November 26-through-February 28 pricing-page coverage remains post-rollout continuity evidence rather than a second causal test, and the January 1-through-February 28 CS auto-nudge lane remains limited to system-control performance. Owen, Ines, and Daniela confirmed the applicable source and limit sections for those three board-ready lanes. Tomás approved my operating-evidence section containing those three lanes without adding a Helio Start forecast claim. Update `Quarterly board operating evidence intake — Q1 2026` with the final review decision, Tomás’s approved three-lane section, the final claims and limits, and Helio Start’s continuing exclusion and `not board-ready` status.